Teresa Affrunti
Family · Highlands Ranch, CONPI 1316427495
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Painteq LLC at 27.3% of the total. Reporting peaked in 2022 at $6,949 and has fallen 96.9% since, to $214 in 2025. Among family clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 366 payments — averaging $55.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Painteq LLC$6K
- Boston Scientific$3K
- Saluda Medical Americas, Inc.$2K
- Medtronic$2K
- AbbVie$1K
- Vertos Medical, Inc.$1K
- plus $5K from 24 others
What the payments were for
- Consulting fees$5,45427%
- Travel & lodging$6,31831%
- Food & beverage$8,34041%
- Education$540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Painteq LLC | 12 | $5,507 |
| Boston Scientific | 43 | $3,412 |
| Saluda Medical Americas, Inc. | 17 | $2,245 |
| Medtronic | 17 | $1,660 |
| AbbVie(2 entities) | 80 | $1,391 |
| Vertos Medical, Inc. | 7 | $1,383 |
| Spinal Simplicity, LLC | 15 | $1,295 |
| Collegium Pharmaceutical, Inc. | 58 | $927 |
| Pfizer | 28 | $410 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $315 |
| Amgen | 8 | $221 |
| GRT US Holding, Inc. | 8 | $207 |
| Scilex Pharmaceuticals Inc. | 12 | $186 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $178 |
| Abbott | 2 | $163 |
| Tactile Systems Technology Inc | 2 | $132 |
| Lilly USA, LLC | 8 | $121 |
| Biohaven Pharmaceuticals, Inc. | 4 | $90 |
| Almatica Pharma LLC | 2 | $49 |
| Bioventus LLC | 3 | $45 |
| Biodelivery Sciences International, Inc. | 3 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Nevro Corp. | 1 | $22 |
| Vertex | 1 | $22 |
| MML US, Inc. | 1 | $21 |
| Novartis | 1 | $21 |
| Redhill Biopharma Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Convatec Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PAINTEQ$5,399
- WAVEWRITER ALPHA$2,231
- Evoke$1,938
- mild Device Kit$1,332
- VANTA ADAPTIVESTIM$1,183
- HA MINUTEMAN G3-R$1,122
- WaveWriter Alpha Prime 16$169
- ETERNA$144
- Superion Indirect Decompression System$141
- GENERAL PAIN MANAGEMENT$121
- Flexitouch Plus$110
- Nimbl$110
How this compares
$20,166 in reported general payments places this provider in the 95th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 74 | $63,321 |
| Xtampza ErOxycodone Myristate | 117 | $42,365 |
| Buprenorphine | 112 | $21,194 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 522 | $15,646 |
| MovantikNaloxegol Oxalate | 33 | $15,639 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 446 | $15,038 |
| Oxycodone Hcl | 569 | $11,078 |
| SymproicNaldemedine Tosylate | 19 | $8,853 |
| Morphine Sulfate ErMorphine Sulfate | 338 | $8,831 |
| Nucynta ErTapentadol Hcl | 15 | $8,731 |
| Gabapentin | 276 | $7,364 |
| Hysingla ErHydrocodone Bitartrate | 15 | $5,422 |
| Lidocaine | 25 | $2,814 |
| Pregabalin | 103 | $2,666 |
| Fentanyl | 30 | $2,618 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er | $927 | $114,417206 claims |
| Redhill Biopharma Inc.Movantik | $19 | $15,63933 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,182 family providers in Colorado.
Other family in Highlands Ranch
- Katie TannerHighlands Ranch$10K
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
- Katie NadingDenver$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.